Feed AIAGY
AI

Aurubis AG AIAGY · OTC

$75.96 +1.21% (+$0.91)

Summary

71 / 100 · Bulios Score

What speaks for it

  • It earns 13 EUR a year on every 100 EUR of invested capital.
  • Analysts expect revenue to grow by 41% this fiscal year.

What to watch

  • The share price is above the Bulios Fair Price.
  • Earnings per share fell by 11% a year over the last 3 years.
  • It reports a profit, yet spends more cash than it brings in.
  • It passes only 3 of the 9 points of the Piotroski financial health test.

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Score in detail

Price

Is it expensive?

Looks expensive
Bulios Fair Price
Current price $75.96
P/E today 5.8 35% lower
5-year average P/E 9.0
P/E today 5.8
Copper industry median

Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?

Today you pay 5.8 EUR for 1 EUR of yearly profit. Over the last five years it was 9.0 EUR on average.

Valuation in detail

Is it growing?

It is shrinking

Revenue (EUR)

Diluted EPS (EUR)

  • Analyst estimate

Revenue grew by 7.9% a year over 5 years. Over the last 3 years it fell by 0.6% a year. For the next fiscal year analysts expect revenue to grow by 41%. Earnings per share fell by 11% a year over the last 3 years.

Growth in detail

Does it make money?

Poorly

Where 100 EUR of revenue goes

Net profit, industry median (Copper) 11 EUR

Out of every 100 EUR of revenue, 4.5 EUR is left as net profit.

Profitability in detail

Is it financially healthy?

Debt is a burden

Over the last 12 months it spent more cash than it brought in. Its debt is larger than its cash. The debt score is high even though free cash flow is negative.

Financial health in detail

Does it pay a dividend?

Small, at risk
Yield
1.26%
Paid out of profit
7.3%
Raised in a row
1 year

You receive $0.95 per share a year. The payout is more than the company can comfortably cover.

Dividends in detail

What do analysts expect?

Neutral

No analyst has published a price target.

33% of the analysts recommend buying.

Analysts in detail

What does it earn on?

By product

The company reports no revenue by product.

By region

The company reports no revenue by region.

Segments in detail

We use essential cookies to run the website and optional analytics cookies to measure usage.

Privacy policy